What we offer
Synexus offers the pharmaceutical industry an alternative, or even more boldly, an answer to the outdated, slow and expensive alternative method of recruiting and retaining patients for clinical trials.
Via its global network Synexus offers clients access to millions of patients, however the benefits of Synexus go far beyond this and also include:
To begin with…
- A reliable, complimentary feasibility assessment designing to mitigate risk;
And then…
- Fast set-up;
- Accelerated recruitment;
- Access to a large and diverse patient population drawn from varying communities throughout the UK, Central Eastern Europe, South Africa and India;
- The capacity to handle studies involving mass screening and large numbers of patients;
- Provision of a single point of contact and highly-experienced Project Management;
And finally…
- The provision of quality data from experience GCP-trained staff;
- And peace of mind brought about by two successful FDA inspections and one MHRA Statutory GCP Inspection.